Effect of zaleplon, a non-benzodiazepine hypnotic, on melatonin secretion in rabbits

Journal of Pharmacological Sciences

Volumn 93, Issue 2, 2003, Pages 204-209

  Noguchi, Hideaki ^a   Kitazumi, Kazuhiro ^a   Mori, Megumi ^a   Shiobara, Yoji ^a   Shiba, Toshiharu ^a  

^a Wyeth Lederle Japan Ltd   (Japan)

Author keywords

cAMP; Melatonin; Pinealocyte; Zaleplon

Indexed keywords

BENZODIAZEPINE RECEPTOR BLOCKING AGENT; CYCLIC AMP; FLUMAZENIL; HYPNOTIC AGENT; ISOBUTYLMETHYLXANTHINE; ISOPRENALINE; MELATONIN; TRIAZOLAM; ZALEPLON; ZOPICLONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHRONOBIOLOGY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DOSE REGIMEN; HORMONE BLOOD LEVEL; HORMONE RELEASE; INTRACELLULAR FLUID; MALE; NONHUMAN; PINEALOCYTE; RABBIT; RADIOIMMUNOASSAY; RAT; STATISTICAL ANALYSIS;

ACETAMIDES; ANIMALS; CELLS, CULTURED; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; HYPNOTICS AND SEDATIVES; MALE; MELATONIN; PINEAL GLAND; PIPERAZINES; PYRIMIDINES; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; TRIAZOLAM;

EID: 0242720564     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.204     Document Type: Article

References (35)

1. Beer B, Clody DE, Mangano R, Levner M, Mayer P, Barrett JE. A review of the preclinical development of zaleplon, a novel non-benzodiazepine hypnotic for the treatment of insomnia. CNS Drug Rev. 1997;3:207-224.
2. Noguchi H, Kitazumi K, Mori M, Shiba T. Binding and neuropharmacological profile of zaleplon, a novel nonbenzodiazepine sedative/hypnotic. Eur J Pharmacol. 2002;434:21-28.
3. Beer B, Ieni JR, Wu W-H, et al. A placebo-controlled evaluation of single, escalating doses of CL284,846, a non-benzodiazepine hypnotics. J Clin Pharmacol. 1994;34:335-344.
4. Vanover KE, Barrett JE. Evaluation of the discriminative stimulus effects of the novel sedative-hypnotic CL284,846. Psychopharmacology (Berl). 1994;115:289-296.
5. Walsh JK, Fry J, Erwin CW, Scharf M, Roth T, Vogel GW. Efficacy and tolerability of 14-days administration of zaleplon 5 mg and 10 mg for the treatment of primary insomnia. Clin Drug Invest. 1998;16:347-354.
6. Claustrat B, Brun J, David M, Sassolas G, Chazot G. Melatonin and jet lag: Confirmatory result using a simplified protocol. Biol Psychiatry. 1986;32:705-711.
7. Palm L, Blennow G, Wetterberg L. Correction of non-24-hour sleep/wake cycle by melatonin in a blind retarded boy. Ann Neurol. 1991;29:336-339.
8. Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD. Delayed sleep phase syndrome response to melatonin. Lancet. 1991;337:1121-1124.
9. Cagnacci A, Elliott JA, Yen SS. Melatonin: A major regulation of the circadian rhythm of core temperature in humans. J Clin Endocrinol Metab. 1992;75:447-452.
10. Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336:186-195.
11. Okudaira N, Itagaki A, Tahara K, Suenaga K, Sasaki M. Effect of triazolam on resynchronizing process of night sleep after eastward flight - A pilot study. J Psychiatry Neurol. 1990;44:177-178.
12. Lavie P: Effect of midazolam on sleep disturbances associated with westward and eastward flight: Evidence for directional effect. Psychopharmacology (Berl). 1990;101:250-254.
13. 3H-melatonin in the cultured rat pineal gland. J Pharmacol Exp Ther. 1973;186:516-527.
14. Grota LJ, Snieckus V, De Silva SO, et al. Radioimmunoassay of melatonin in rat serum. Prog Neuro-Psychopharmacol. 1981;5:523-526.
15. Olcese J. Neuropeptide Y: An endogenous inhibitor of norepinephrine-stimulated melatonin secretion in the rat pineal gland. J Neurochem. 1991;57:943-947.
16. Takao Y, Shimanoto C, Hirata I, Ohshiba S. The effect of acid secretagogues on mucin synthesis using primary monolayer culture of the guinea pig gastric mucous cells. Gastroenterol Jpn. 1993;28:638-646.
17. Marczynski TJ, Yamaguchi N, Ling GM, Gordzinka L. Sleep induced by the administration of melatonin to the hypothalamus in unrestrained cats. Experimentia. 1964;20:435-437.
18. Holmes SW, Sugden D. Effects of melatonin on sleep and neurochemistry in the rat. Br J Pharmacol. 1982;76:95-101.
19. Cramer H, Rudolph J, Consbrush U, Kendel K. On the effects of melatonin on sleep and behavior in man. In: Costa E, Gessa GL, Sanger M, editors. Biochemistry and Behavioral and Clinical Studies. New York: Raven Press; 1974. p. 187-191.
20. Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet. 1995;346:541-543.
21. Arendt J, Aldhous M, Wright J. Synchronization of a disturbed sleep-wake cycle in a blind man by melatonin. Lancet. 1998;2:772-773.
22. Klein DC, Weller JL. Indole metabolism in the pineal gland: A circadian rhythm in N-acetyltransferase. Science. 1979;169:1093-1095.
23. Brainard GC, Matthews SA, Steger RW, Reiter RJ, Asch RH. Day:night variations of melatonin, 5-hydroxyindole acetic acid, serotonin, serotonin N-acetyltransferase, tryptophan, norepinephrine and dopamine in the rabbit pineal gland. Life Sci. 1984;35:1615-1622.
24. Sugden D. Melatonin biosynthesis in the mammalian pineal gland. Experientia. 1989;45:922-932.
25. Monia ZA, Abdallah G, Claude G, Sarda N. Docosahexaenoic acid reduces both cyclic nucleotide and melatonin synthesis in rat pinealocytes. Prostaglandins. 1998;55:291-300.
26. Pooley L. Type IV phosphodiesterase activity specifically regulates cAMP-stimulated casein secretion in the rat mammary gland. Biochim Biophys Acta. 2002;1590:84-92.
27. Moriyama Y, Yamamoto A, Yamada H, Tashiro Y, Futai M. Role of endocrine cell microvesicles in intercellular chemical transduction. Biol Chem Hoppe Seyler. 1996;377:155-165.
28. Pujito PP, Govitrapong P, Ebadi M. Inhibitory actions of muscarinic cholinergic receptor agonists on serotonin N-acetyltransferase in bovine pineal explants in culture. Neurochem Res. 1991;16:885-889.
29. Olcese J, Muller D, Munker M, Schmidt C. Natriuretic peptides elevate cyclic 3′,5′-guanosine monophosphate levels in cultured rat pinealocytes: Evidence for guanylate cyclase-linked membrane receptors. Mol Cell Endocrinol. 1994;103:95-100.
30. Schaad NC, Vanecek J, Rodriguez IR, Klein DC, Holtzclaw L, Russell JT. Vasoactive intestinal peptide elevates pinealocyte intracellular calcium concentrations by enhancing influx: Evidence for involvement of a cyclic GMP-dependent mechanism. Mol Pharmacol. 1995;47:923-933.
31. 1 receptors in bovine pinealocytes. Brain Res. 2002;951:23-30.
32. Nicholls J, Skene DJ, Hourani SM. Use of a newly developed technique to isolate rat pinealocytes and study the effects of adenosine agonists on melatonin production. J Pineal Res. 1997;23:164-168.
33. Mikkelsen JD, Hauser F, Olcese J. Neuropeptide Y (NPY) and NPY receptors in the rat pineal gland. Adv Exp Med Biol. 1999;460:95-107.
34. 2C receptor involvement. J Pharmacol Exp Ther. 2000;295:266-273.
35. Ng TB, Wong CM. Effects of pineal indoles and arginine vasotocin on lipolysis and lipogenesis in isolated adipocytes. J Pineal Res. 1986;3:55-66.